HighTower Advisors’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-200
Closed -$7K 3468
2021
Q1
$7K Buy
+200
New +$2.22K ﹤0.01% 2947

Other funds holding LUXA

HighTower Advisors's LUXA Position: Q2 2021 in Review

HighTower Advisors sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q2 2021, closing a stake of 23,000 shares — an estimated $236K sold.

HighTower Advisors first reported a position in LUXA in Q4 2020 and held it in 2 quarters. The position peaked at $1.23M in Q4 2020. 55 funds tracked by Wall St. Rank hold LUXA as of Q2 2021.

  • HighTower Advisors reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • HighTower Advisors sold 23,000 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q2 2021, an estimated $236K.
  • HighTower Advisors first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q4 2020 and held it in 2 quarters.
  • HighTower Advisors's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $1.23M in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q2 2021.

Based on HighTower Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.